Adjunctive treatment in patients treated with thrombolytic therapy.
作者信息
Brouwer M A, Clappers N, Verheugt F W A
机构信息
Department of Cardiology, Heartcenter, University Medical Center Nijmegen, The Netherlands.
出版信息
Heart. 2004 May;90(5):581-8. doi: 10.1136/hrt.2003.019877.
Abstract
摘要
相似文献
1
Adjunctive treatment in patients treated with thrombolytic therapy.接受溶栓治疗患者的辅助治疗。
Heart. 2004 May;90(5):581-8. doi: 10.1136/hrt.2003.019877.
2
Acute myocardial infarction.急性心肌梗死
Clin Evid. 2003 Dec(10):37-63.
3
Acute myocardial infarction.急性心肌梗死
Clin Evid. 2003 Jun(9):22-49.
4
Myocardial infarction.心肌梗死
Clin Evid. 2006 Jun(15):140-63.
5
Acute myocardial infarction.急性心肌梗死
Clin Evid. 2004 Dec(12):20-50.
6
Adjunctive therapy for myocardial infarction.心肌梗死的辅助治疗
Arq Bras Cardiol. 1995 Jul;65(1):97-110.
7
Management of acute coronary syndromes.急性冠状动脉综合征的管理
Am J Respir Crit Care Med. 2001 Sep 15;164(6):917-22. doi: 10.1164/ajrccm.164.6.2101047.
8
[Pharmacotherapy after cardiac infarction].[心肌梗死后的药物治疗]
Internist (Berl). 2001 May;42(5):699-712. doi: 10.1007/s001080050811.
9
Adjunctive use of beta-adrenergic blockers, calcium antagonists and other therapies in coronary thrombolysis.β-肾上腺素能阻滞剂、钙拮抗剂及其他疗法在冠状动脉溶栓中的辅助应用。
Am J Cardiol. 1991 Jan 25;67(3):25A-31A. doi: 10.1016/0002-9149(91)90085-y.
10
Adjunctive pharmacologic therapy for acute myocardial infarction.急性心肌梗死的辅助药物治疗
Clin Cardiol. 1994 Jan;17(1 Suppl 1):I10-4.
本文引用的文献
1
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.ST段抬高型急性心肌梗死患者的管理。欧洲心脏病学会急性心肌梗死管理特别工作组。
Eur Heart J. 2003 Jan;24(1):28-66. doi: 10.1016/s0195-668x(02)00618-8.
2
Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study.急性心肌梗死中直接血管成形术与院前纤维蛋白溶解术的随机研究
Lancet. 2002 Sep 14;360(9336):825-9. doi: 10.1016/S0140-6736(02)09963-4.
3
Oral anticoagulation for acute coronary syndromes.急性冠状动脉综合征的口服抗凝治疗。
Circulation. 2002 Mar 19;105(11):1270-4. doi: 10.1161/hc1102.105594.
4
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.抗血小板治疗预防高危患者死亡、心肌梗死和中风的随机试验协作荟萃分析。
BMJ. 2002 Jan 12;324(7329):71-86. doi: 10.1136/bmj.324.7329.71.
5
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.替奈普酶与依诺肝素、阿昔单抗或普通肝素联合使用的疗效和安全性：急性心肌梗死的ASSENT-3随机试验
Lancet. 2001 Aug 25;358(9282):605-13. doi: 10.1016/S0140-6736(01)05775-0.
6
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.急性心肌梗死的再灌注治疗：采用纤溶疗法或联合降低纤溶疗法及血小板糖蛋白IIb/IIIa抑制作用的治疗——GUSTO V随机试验
Lancet. 2001 Jun 16;357(9272):1905-14. doi: 10.1016/s0140-6736(00)05059-5.
7
Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences.纤维蛋白溶解疗法治疗急性心肌梗死后立即进行血管成形术的综述：来自RESCUE I、RESCUE II及其他当代临床经验的见解
Am Heart J. 2000 Jun;139(6):1046-53. doi: 10.1067/mhj.2000.106624.
8
Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis.急性心肌梗死的死亡率与院前溶栓治疗：一项荟萃分析。
JAMA. 2000;283(20):2686-92. doi: 10.1001/jama.283.20.2686.
9
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.阿昔单抗可促进溶栓的速度和程度：心肌梗死溶栓治疗（TIMI）14试验的结果。TIMI 14研究人员。
Circulation. 1999 Jun 1;99(21):2720-32. doi: 10.1161/01.cir.99.21.2720.
10
Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.急性心肌梗死患者接受组织型纤溶酶原激活剂治疗后发生颅内出血的风险。心肌梗死全国注册研究2的参与者。
Ann Intern Med. 1998 Oct 15;129(8):597-604. doi: 10.7326/0003-4819-129-8-199810150-00002.
Zotero 插件